6 Best Precious Metals Investment Storage in 2026

Discover the top 6 precious metals investment storage options for 2026. Find out which solutions protect your wealth and suit your investment style best.

Global tech stocks fall as Asian memory chipmakers hammered

Global technology stocks fell sharply today, driven by significant losses among Asian memory chipmakers amid market concerns over demand and supply issues.

Bitcoin nears the $58,000 floor that has marked every cycle bottom since 2015

Bitcoin nears the $58,000 level, a key support point that has marked every cycle bottom since 2015, raising questions about future price movements.

Neuberger Berman Surges In Global Coverage

Neuberger Berman has experienced a surge in global media mentions, with 14 reports in a recent window, indicating increased public and industry attention.

Gold IRA & Precious Metals Checklist 2026

If you’re considering a Gold IRA or precious metals investment in 2026,…

Updating Beneficiaries After Life Changes: the Family Planning Detail That Prevents Chaos

Discover how updating beneficiaries after life changes can prevent chaos and ensure your wishes are honored—learn the crucial steps to protect your family’s future.

Dividend Investing vs Total Return in IRAs: The Allocation Lesson Hidden in Plain Sight

Wondering whether to prioritize dividend investing or total return in your IRA? Discover the hidden lesson that could shape your retirement strategy.

ADMA Investors Have Opportunity To Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed By The Rosen Law Firm

Investors in ADMA Biologics have the opportunity to lead a securities fraud lawsuit filed by The Rosen Law Firm, alleging misconduct related to company disclosures.

First Hawaiian To Report Second Quarter 2026 Financial Results On July 24, 2026

First Hawaiian will report its second quarter 2026 financial results on July 24, 2026, with investors and analysts awaiting the earnings release.

Deepening Collaboration In AI-Powered R&D Acceleration: Insilico Medicine And CMS Announce Additional Collaborations In CNS Diseases

Insilico Medicine and CMS have announced an extension of their partnership to accelerate AI-powered research in central nervous system diseases, aiming to improve drug discovery.